When the dual PI3K/mTOR inhibitor CCT128930 is applied to OS cells lines (MG63, U2OS, and Saos‐2), cyclin D1 and/or cyclin B1 expression was downregulated in tumor cells, and the cell cycle was stalled at the G0/G1 phase.218. The gene discussed is MTOR; the disease is neoplasm.